Last update 21 Nov 2024

Milrebrutinib

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Docirbrutinib
+ [1]
Target
Mechanism
BTK C481S inhibitors(Bruton Tyrosine Kinase C481S inhibitors)
Originator Organization
Active Organization
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC33H31FN6O3
InChIKeyLJODJUIHONTDMR-UHFFFAOYSA-N
CAS Registry2227211-00-7

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
B-Cell Malignant NeoplasmPhase 1
US
01 Aug 2023
Follicular LymphomaPhase 1
US
01 Aug 2023
Mantle-Cell LymphomaPhase 1
US
01 Aug 2023
Marginal Zone B-Cell LymphomaPhase 1
US
01 Aug 2023
Waldenstrom MacroglobulinemiaPhase 1
US
01 Aug 2023
B-Cell LymphomaDiscovery
CN
01 Jul 2022
Chronic Lymphocytic LeukemiaDiscovery
CN
01 Jul 2022
Chronic Lymphocytic LeukemiaDiscovery
CN
01 Jul 2022
Small Lymphocytic LymphomaDiscovery
CN
01 Jul 2022
Diffuse Large B-Cell LymphomaDiscovery
JP
22 Oct 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
-
rnajyecuaw(kheakqcayf) = ewqovnxelt kwwljsnviu (gasiwhpqit )
-
15 Jun 2022
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free